Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye
about
NSABP breast cancer clinical trials: recent results and future directionsCurrent status of sentinel lymph node biopsy in solid malignanciesThe inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachSentinel lymphnode biopsy in early breast cancer using methylene blue dye and radioactive sulphur colloid - a single institution Indian experience.Nano-sized fluorescent particles as new tracers for sentinel node detection: experimental model for decision of appropriate size and wavelength.Intraoperative Injection of Technetium-99m Sulfur Colloid for Sentinel Lymph Node Biopsy in Breast Cancer Patients: A Single Institution Experience.Breast cancer.Sentinel lymph node--why study it: implications of the B-32 study.Breast cancer sentinel node metastases: histopathologic detection and clinical significance.Sentinel lymph node biopsy in patients with melanoma and breast cancer.Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer--a prospective studyOptimal use of sentinel lymph node biopsy versus axillary lymph node dissection in patients with breast carcinoma: a decision analysis.Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits.The impact of previous para-areolar incision in the upper outer quadrant of the breast on the localization of the sentinel lymph node in a canine model.Alternative sites of injection for sentinel lymph node biopsy in breast cancer.Contraindications of sentinel lymph node biopsy: are there any really?How many sentinel lymph nodes are enough for accurate axillary staging in t1-2 breast cancer?Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green.The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis.Breast conservation: current results and future perspectives at the European Institute of Oncology.Sentinel node biopsy in larger or multifocal breast cancers: to do or not to do.Measuring the quality of sentinel lymph node biopsy in breast cancer using newly developed quality indicators: a feasibility study.Factors influencing the identification rate of the sentinel node in breast cancer.Axillary recurrence rate in breast cancer patients with negative sentinel lymph node biopsy or containing micrometastases and without further lymphadenectomy: a monocentric review of 8 years and 481 cases.The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of care.Sentinel node biopsy for breast cancer: past, present, and future.Timing of determining axillary lymph node status when neoadjuvant chemotherapy is used.A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: a focus on older women.Impact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancer.Recent advances in near-infrared fluorescence-guided imaging surgery using indocyanine green.Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.Trends and controversies in multidisciplinary care of the patient with breast cancer.Measuring the quality of sentinel lymph node biopsy (SLNB) for breast cancer: a population-based evaluation.Outcomes following sentinel lymph node biopsy for breast cancer.How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer.Breast Cancer Sentinel Node Detection: An Alternative Solution for Centers Lacking Nuclear TechnologyEfficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer.Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.Value of sentinel lymph node biopsy in breast cancer patients with previous excisional biopsy.
P2860
Q24520573-776B1AFF-AE99-4A0A-9A17-F076148B2AE9Q24803828-97033BF4-282E-4E7F-9660-1C07DA77D479Q26765937-3D16A687-6589-4625-9929-876168CE3A8CQ30461280-F1A21A0E-07CB-462B-80A0-C57DA684B7D8Q33217190-8E081BF0-8885-4330-91E2-F71C2878B301Q33608067-69D21229-E706-4F58-B7D6-13D847267C6FQ33809186-AA3760AF-B968-407C-8A06-19A7112C1EA1Q34346880-83B6D742-B789-456A-A902-33E668AD1E76Q34386701-6CA08904-A4F9-4E22-98FF-09E7186DEA7CQ34478231-19E12D87-E249-4F48-9DD7-FF1554133373Q34585753-D885F157-9CCF-4581-A3D8-8B3B53A15F49Q34810831-64084D4A-DA98-41C0-A008-22C6A203D6C0Q35157554-A78FB619-329C-41BE-8014-E59464913889Q35179731-B7249295-C03D-4BCF-A398-3BD9FD2902E6Q35187549-94593D7C-9366-41D3-8073-4A27EAE12FEDQ35634145-A7367E0B-4611-4B43-9892-A9C40899576DQ35713840-D46125BF-776D-4328-87D4-EE71A8D8DC41Q35721357-F41097DF-8767-4199-9F45-8C01D5B5F903Q36311712-2913BA37-EE7A-45B5-99FC-EA86098742A5Q36702861-95953B3A-6427-40CC-8062-C7A01E06B6D2Q37082866-A852633B-FCD3-451B-87F1-5B72F7B4737EQ37772123-031763B0-272E-4596-9B74-DA3241C3A5FDQ37847634-3EBCF1E9-A584-4436-AC27-7EE33C9BDF4AQ37900684-4E4E21F8-070F-424B-BE08-5CC1F472164CQ38021382-EA99C176-2835-44CA-8B7F-9D096C02B4EEQ38068375-F14B6883-983C-469B-9511-3E395EEA1222Q38180308-B3C3B304-3646-47F0-8842-2278C2754C3BQ38183099-FA471531-7E85-4431-AADF-C3DEE6E38628Q38366389-601C5384-FDA2-4BCF-8F18-DBC85B7E6AC1Q38395243-E2880706-C7CE-41E1-9C0F-4B5AD5CCA688Q38409756-BBA667F6-2197-47D9-892E-AAF91959BBF7Q39119467-C91D7173-BE6E-4574-86C3-53542F0184CBQ40060519-3EABA4BE-97E6-4B93-A10E-8E3CA2DF71E0Q40169380-0DBA73EB-9CB2-4E07-B28A-CA63C9547F71Q40763024-80A22FEA-74D6-47AE-A4B6-DAD67BDD7A4EQ41051181-E531126A-3402-4652-8921-48451CF3B7C0Q41212387-EC8ECE73-CAB9-43CC-8E7D-26A4BEB6AF73Q41846391-9F82E5DF-8B77-4924-9A8D-038EF0B66F8FQ42026408-58C38AC6-B4DB-442B-BDE8-3CAE664FE7F5Q42559299-974F5E25-3B11-44DE-ABEC-FA94C2EB3997
P2860
Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Multicenter trial of sentinel ...... colloid and isosulfan blue dye
@ast
Multicenter trial of sentinel ...... colloid and isosulfan blue dye
@en
Multicenter trial of sentinel ...... colloid and isosulfan blue dye
@nl
type
label
Multicenter trial of sentinel ...... colloid and isosulfan blue dye
@ast
Multicenter trial of sentinel ...... colloid and isosulfan blue dye
@en
Multicenter trial of sentinel ...... colloid and isosulfan blue dye
@nl
prefLabel
Multicenter trial of sentinel ...... colloid and isosulfan blue dye
@ast
Multicenter trial of sentinel ...... colloid and isosulfan blue dye
@en
Multicenter trial of sentinel ...... colloid and isosulfan blue dye
@nl
P2093
P2860
P1433
P1476
Multicenter trial of sentinel ...... colloid and isosulfan blue dye
@en
P2093
B E Halliday
C M Carman
D R Lannin
K M Verbanac
L M Sommers
P2860
P356
10.1097/00000658-200101000-00009
P407
P577
2001-01-01T00:00:00Z